Mirae Asset Global Etfs Holdings Ltd. Innoviva, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 34,505 shares of INVA stock, worth $603,147. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,505
Previous 32,882
4.94%
Holding current value
$603,147
Previous $596,000
16.28%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding INVA
# of Institutions
283Shares Held
80.4MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$125 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$110 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$83.2 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$75.1 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.22B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...